TNF receptor associated periodic syndrome
Autosomal dominant autoinflammatory disorder
| TNF Receptor-Associated Periodic Syndrome (TRAPS) | |
|---|---|
| |
| Synonyms | Familial Hibernian Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome |
| Pronounce | |
| Field | Rheumatology, Immunology |
| Symptoms | Recurrent fever, rash, abdominal pain, myalgia, periorbital edema |
| Complications | Pericarditis, amyloidosis, uveitis, splenomegaly |
| Onset | Childhood or early adulthood |
| Duration | Chronic, episodic flares |
| Types | |
| Causes | Mutations in the TNFRSF1A gene[1] |
| Risks | Genetic predisposition (autosomal dominant inheritance) |
| Diagnosis | Blood test, genetic testing, clinical evaluation |
| Differential diagnosis | Familial Mediterranean fever, CAPS, Still's disease |
| Prevention | None known |
| Treatment | Corticosteroids, NSAIDs, Biologic therapy (e.g., etanercept, infliximab) |
| Medication | TNF inhibitors, IL-1 blockers |
| Prognosis | Chronic, may lead to complications like amyloidosis if untreated |
| Frequency | Rare |
| Deaths | Rare (if amyloidosis develops) |
TNF Receptor-Associated Periodic Syndrome (TRAPS) is a rare autoinflammatory disorder characterized by recurrent episodes of fever, inflammation, and pain. It is caused by mutations in the TNFRSF1A gene, which encodes the tumor necrosis factor receptor-1 (TNFR1). TRAPS follows an autosomal dominant inheritance pattern, meaning a single copy of the defective gene can lead to the disorder.[2]
Symptoms and Signs
TRAPS presents with episodic inflammatory attacks lasting days to weeks, with variable severity. The most common symptoms include:[3]
- Recurrent fevers – Lasting longer (usually >7 days) than fevers seen in other periodic fever syndromes.
- Inflammatory symptoms:
- Painful erythematous skin rashes (often migratory and resembling cellulitis)
- Myalgia (muscle pain) – Deep, aching pain in the limbs and trunk
- Periorbital edema (puffy eyes)
- Severe abdominal pain, nausea, vomiting, or diarrhea during attacks
- Long-term complications:
- Pericarditis – Inflammation of the heart lining
- Splenomegaly – Enlarged spleen
- Amyloidosis – A serious long-term complication leading to kidney failure
- Uveitis and vertigo (less common)
Causes
TRAPS is caused by mutations in the TNFRSF1A gene on chromosome 12 (12p13.31).[4] These mutations impair the body's normal inflammatory response by disrupting tumor necrosis factor (TNF) signaling, leading to excessive inflammation.
TRAPS follows an autosomal dominant inheritance pattern, meaning an affected person has a 50% chance of passing the condition to their children.
Pathophysiology
TRAPS is caused by a dysfunctional TNF receptor-1 (TNFR1), leading to: 1. Impaired TNF signaling – Resulting in prolonged and exaggerated inflammatory responses. 2. Dysregulation of immune cells – Macrophages and neutrophils remain overactive, leading to tissue damage. 3. Increased pro-inflammatory cytokines – Elevated IL-1β, IL-6, and TNF-alpha contribute to fever and systemic inflammation.[5]
Diagnosis
The diagnosis of TRAPS is based on clinical presentation, laboratory tests, and genetic testing.[6]
Diagnostic Criteria 1. Clinical evaluation – Recurrent fever episodes (>7 days), migratory rash, muscle pain. 2. Blood tests:
- Elevated inflammatory markers (CRP, ESR, serum amyloid A)
- Elevated IgD (in some cases)
3. Genetic testing – Identifies mutations in the TNFRSF1A gene.
Differential Diagnosis
TRAPS must be differentiated from other autoinflammatory syndromes, including:
- Familial Mediterranean Fever (FMF) – Shorter episodes, autosomal recessive inheritance.
- Cryopyrin-Associated Periodic Syndromes (CAPS) – Includes Muckle-Wells syndrome and FCAS.
- Still’s Disease – Persistent fever, arthritis, and rash.
Treatment
There is no cure for TRAPS, but treatment aims to control inflammation and prevent complications.[3]
First-Line Treatments
- Corticosteroids (e.g., prednisone) – Reduce symptom severity but have long-term side effects.
- NSAIDs – Provide symptom relief for fever and pain.
Biologic Therapies For moderate-to-severe cases, TNF inhibitors and IL-1 blockers are used:
- Etanercept – A TNF-receptor blocker, effective in reducing flare frequency.
- Infliximab and Adalimumab – Have mixed results; some cases worsen symptoms.
- Anakinra (IL-1 blocker) – May be more effective than TNF inhibitors in some patients.[7]
Complication Management Patients with amyloidosis require renal function monitoring and may need IL-1 inhibitors or colchicine.
Prognosis
TRAPS is a lifelong condition, with variable severity. If untreated, complications such as amyloidosis and kidney failure can develop. With appropriate treatment and monitoring, most patients can manage symptoms and prevent major complications.
See Also
| Medicine | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
 | |
|---|---|
 |
 |
- ↑ TRAPS(link). Genetics Home Reference. Accessed 3 January 2018.
- ↑ , TNF-receptor-associated periodic syndrome (TRAPS): an autosomal dominant multisystem disorder, Clinical Rheumatology, Vol. 25(Issue: 6), pp. 773–777, DOI: 10.1007/s10067-005-0198-6, PMID: 16447098,
- ↑ 3.0 3.1 TNF Receptor-Associated Periodic Syndrome (TRAPS) - Genetic and Rare Diseases Information Center (GARD)(link). {{{website}}}. Accessed 2025-03-18.
- ↑ OMIM Gene Map - Chromosome: 12(link). OMIM. Accessed 2025-03-18.
- ↑ Wajant, H., Tumor necrosis factor signaling, Cell Death & Differentiation, Vol. 10(Issue: 1), pp. 45–65, DOI: 10.1038/sj.cdd.4401189, PMID: 12655295,
- ↑ TNF receptor-associated periodic fever syndrome (TRAPS) - Genetic Testing Registry(link). NCBI. Accessed 2025-03-18.
- ↑ , Hereditary auto-inflammatory disorders and biologics, Springer Semin Immunopathol, Vol. 27(Issue: 4), pp. 494–508, DOI: 10.1007/s00281-006-0015-6, PMID: 16738958,
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
